2021 Call for Poster Abstracts - Applications have closed

The Virtual Poster Session which will take place during the Annual Meeting and participate in a 1-hour question & answer session with our poster presenters for CE credit. Poster Presentations are a means of communication of new ideas and services with your colleagues. An Interactive Poster Session (ACPE Approved) will be featured. The goal is to encourage networking and enhance member involvement in our educational program. All posters are peer reviewed and approved by the Annual Meeting Committee. Note all poster session presenters must register for the Annual Meeting in order to present.

Deadlines & Information:

  • All topics and abstracts should be submitted on or before Friday, April 16, 2021 via email to [email protected]. See below for guidelines for submitting abstracts. - Applications have closed
  • An email will be sent by April 26th, 2021 containing abstract submission results. For those who receive an acceptance e-mail, you will receive details regarding how we will present posters this year. You will need to prepare the following by May 7, 2021:
    • One 5 to 7-minute video recording of a power-point presentation of the presenter’s project (include objectives for learning)
    • Abstract submission (already submitted)
    • Traditional Poster in PDF format.
    • 2 Assessment questions (submitted with abstract)
  • Please send above items to LSHP Office by May 7, 2021.
  • If you do not receive a confirmation email from the LSHP office, you have until Friday, April 20, 2021 to contact the LSHP office by telephone or email.

Award & Prize Opportunities:

  • Achievement awards as well as a cash award will be presented in the categories of clinical/pharmaceutical science research, administrative practice, quality improvement and/or innovation projects. In addition, we will present awards for student and residents. Awards will be presented to the practitioner according to abstracts and the poster presentation at the meeting. To encourage membership and member involvement ONLY LSHP members are eligible to receive cash awards (e.g. if the first author is not a member, the award goes to the next author that qualifies in order listed on the poster).
  • Attendees will receive a form with assessment questions where they can keep track of what posters they have visited.

CE Session:

  • Meeting participants will need to attend the 1-hour virtual CE session to receive CE.

Instructions for Preparing Abstracts

Please read the instructions carefully. Research-in-progress is acceptable. There are two abstract types:

Clinical/Pharmaceutical Science, Administrative Research:

  1. Please submit abstract via the form available below. Abstracts will not be processed for review if they are not submitted using the form. Word Limit: 300.
  2. Abstracts should be informative and contain the following elements:
    1. Short specific title. (Upper and lowercase)
    2. Authors who have significantly contributed to the work (5-10)
      1. Presenting author must be listed first.
      2. Include credentials after each person’s name, separated with commas.
    3. Affiliations: List institution(s) where the research was performed.
    4. Purpose: Explain the importance of the research or activity including objectives, goals, and purpose.
    5. Methods: Briefly explain the strategy used to gather the data that is presented.
    6. Results/Expected Results: Outcomes of your study
    7. Discussion/Conclusion: Apply outcomes of the study to purpose and contribute to the respective field.
  3. Font & Style: Single Space, Times New Roman, 12pt font. Headers can be in bold.
  4. Three (3) goals and objectives of the project or study must accompany the poster abstract. This is separate from the abstract and not included in the 300-word limit.
  5. Two (2) questions (preferably that cannot be answered by reading the abstract or poster/handouts) with answers must accompany the abstract. The preferred questions are multiple choice or K-type.
  6. The Curriculum Vitae or resume of the primary author or the presenting author should accompany the abstract or be submitted.

Download Application Form

Administrative, Quality Improvement, and/or Innovation Projects:

  1. Please submit abstract via the form available below. Abstracts will not be processed for review if they are not submitted using the form. Word Limit: 300.
  2. Abstracts should be informative and contain the following elements:
    1. Short specific title
    2. Authors who have significantly contributed to the work (5-10)
      1. Presenting author must be listed first.
      2. Include credentials after each person’s name, separated with commas
    3. Affiliations: List institution(s) where the project was performed.
    4. Purpose: Explain the importance of the project or activity including objectives, goals, and purpose.
    5. Project Description:
      1. Describe the major problem or issue that is addressed by your project, including key factors that need to be solved.
      2. Give information on Best Practice Guidelines used to address the problem/issue, protocols used to incorporate guidelines into practice, strategies used to make improvements.
    6. Discussion/Conclusion: Provide outcomes associated with your project/event and future plans related to your project.
  3. Font & Style: Single Space, Times New Roman, 12pt font. Headers can be in bold.
  4. Three (3) goals and objectives of the project or study must accompany the poster abstract.
  5. Two (2) questions (preferably that cannot be answered by reading the abstract or poster/handouts) with answers must accompany the abstract. The preferred questions are multiple choice or K-type.
  6. The Curriculum Vitae or resume of the primary author or the presenting author should accompany the abstract or be submitted

Download Application Form

Poster Session Objectives:

At the completion of this activity, the pharmacist will be able to:

  1. Review outstanding health-system pharmacy practices or best practices in health-system pharmacy.
  2. Discuss emerging concerns relevant for health-system pharmacy in Louisiana.
  3. Utilize national standards, evidence-based medicine and pharmacy literature to improve medication safety and efficacy.
  4. List the impact of educational programs on safety and pharmacy practice improvement.
  5. Discuss the impact pharmacists or pharmacy technicians can have in patient safety inventions.

At the completion of the activity, the pharmacy technician will be able to:

  1. Review outstanding health-system pharmacy practices or best practices in health-system pharmacy.
  2. Identify emerging concerns relevant for health-system pharmacy in Louisiana.
  3. List the impact of educational programs on safety and pharmacy practice improvement.
  4. Discuss ways that technicians may improve medication safety processes and assist the pharmacist in identifying opportunities to improve medication safety.